腺髓神经病的基因疗法:挑战,目标细胞和前景
Pierre Bougnères1,2, Catherine Le Stunff1,3, Romina Aron Badin1
1Laboratoire des Maladies Neurodégénératives, MIRCen Institute, Commissariat à l'Energie Atomique, 92260 Fontenay-aux-Roses, France.
Biomedicines
|August 28, 2025
概括
基因疗法对X关联上腺缩症 (X-ALD) 是一种神经退行性疾病具有前景. 使用腺相关病毒载体的小鼠模型研究旨在确定治疗这种罕见遗传疾病的最佳点.
科学领域:
- 神经科学
- 遗传学
- 分子生物学
背景情况:
- 与X相关的上腺缩 (X-ALD) 是一种由ABCD1基因突变引起的神经退行性疾病,主要影响脊髓轴突.
- 鉴定参与X-ALD病变的特定细胞类型对于有效的基因治疗向至关重要.
- 腺相关病毒 (AAV) 载体是神经退行性疾病的基因替代疗法的一个有前途的工具.
研究的目的:
- 评估腺相关病毒 (AAV) 基因治疗X链 adrenoleukodystrophy (X-ALD) 的潜力.
- 在X-ALD小鼠模型中研究携带ABCD1基因的AAV载体的疗效.
- 探索不同的治疗策略,包括促进剂,注射途径和干预时间.
主要方法:
- 使用了X-ALD的Abcd1-/-y小鼠模型.
- 采用AAV9基因工程来表达ABCD1基因.
- 测试了各种促进剂 (无处不在和细胞特异性),施用途径和干预年龄.
- 在健康灵长类动物的脊髓中评估转基因表达.
主要成果:
- 基因治疗方法在Abcd1-/-y小鼠模型中显示出有前途的进展.
- 该研究探索了各种参数以优化X-ALD的基因传递和表达.
- 一个灵长类模型的初步调查提供了对矢量行为的洞察.
结论:
- 使用AAV载体的基因替代策略显示出治疗X-ALD的巨大潜力.
- 这些发现支持对AMN患者的基因治疗的开发,特别是在新生儿查时.
- 在症状出现之前的早期干预可能是X-ALD的可行的治疗策略.
更多相关视频
10:28Direct Reprogramming of Human Fibroblasts into Myoblasts to Investigate Therapies for Neuromuscular Disorders
Published on: April 3, 2021
6.5K
10:03Transplantation of Induced Pluripotent Stem Cell-derived Mesoangioblast-like Myogenic Progenitors in Mouse Models of Muscle Regeneration
Published on: January 20, 2014
9.8K
相关概念视频
Gene Therapy
25.8K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.8K
Microorganisms in Medicine and Therapeutics
312
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
312
Myasthenia Gravis: Overview and Treatment
1.9K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.9K
